|Bid||0.00 x 2900|
|Ask||0.00 x 2200|
|Day's Range||19.79 - 20.36|
|52 Week Range||19.79 - 40.12|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||36.16|
|Earnings Date||Nov 17, 2023 - Nov 21, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||26.60|
Subscribe to Yahoo Finance Plus to view Fair Value for DOCS
Worse yet, Enphase Energy (NASDAQ: ENPH), The Toro Company (NYSE: TTC), and Doximity (NYSE: DOCS) are down between 29% and 53% on the year. Posting a jaw-dropping total return north of 2,700% over the last five years -- even after its drop in 2023 -- Enphase and its semiconductor-based microinverters and batteries have been thriving amid the solar industry's boom. Converting energy at the individual solar module level, Enphase's microinverters are superior to solar systems using a string inverter system, which cannot account for partial shading of a solar panel layout as effectively.
Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.
Doximity (NYSE: DOCS) operates a networking platform for doctors that claims to have 80% of U.S. physicians on it. It's an impressive statistic, but that hasn't been enough of a reason for investors continue buying up the stock this year. While other growth stocks have been thriving due to artificial intelligence (AI), there's not the same level of excitement around Doximity -- even though the company has launched its own chatbot, DocsGPT.